CIANJ Commerce Magazine June 2020 | Page 22

Continued From Page 18 medication, rheumatology infusions, iron and hydration. Patients are screened before a consultation appointment is given. Upon arrival, they are required to complete a screening form which is reviewed by a nurse. All patients and employees must submit to temperature checks and are required to wear a mask once inside the building. Social distancing is practiced in all waiting areas and chairs have been removed when necessary to ensure that patients are always sitting six feet apart. Trinitas Regional Medical Center, Trinitas Comprehensive Cancer Center By Barry S. Levinson, M.D., Medical Director People who are actively undergoing treatment for their cancer continue to come to Trinitas Comprehensive Cancer Center in spite of the pandemic. Therefore, our responsibility is to ensure that our patients are as safe as possible from the moment they enter and throughout their stay in the building. One major change we have made is the use of videoconferencing for follow-up appointments. We also teleconference with our peers so we may continue discussing the best ways to treat our patients. Each week, our oncologists’ videoconference with their colleagues throughout the state through the Rutgers/Cancer Institute of New Jersey to discuss best practices. Another change is we have become very active in COVID-related clinical research. For instance, we joined a study to determine the effectiveness of the investigational antiviral drug Remdesivir for emergency use on critically ill patients on ventilators. We launched a study involving stem cell therapy just last week, and we are also participating in a Mayo Clinic trial that is using plasma from patients who have survived COVID. Yet another study is looking at the effectiveness of a drug typically used to treat rheumatoid arthritis. It’s rewarding to use our robust expertise in clinical trials to now help patients with COVID. Valley-Mount Sinai Comprehensive Cancer Care By Eleonora Teplinsky, M.D., Head, Breast Medical Oncology The rapid spread of COVID-19, the need to allocate the majority of healthcare resources to fight the pandemic, and the critical importance of social distancing and self-quarantine to flatten the curve resulted in a significant shift in the treatment of patients with cancer. Each patient’s treatment plan was individually assessed by the healthcare team and care prioritized, adjusted and optimized with the goal of balancing the need and benefit of treatment with the risks to the patient and potential adverse effects that would require increased interaction with the healthcare system. The majority of cancer surgeries were postponed, patients’ imaging tests were canceled, and most non-urgent visits were converted to telemedicine visits. We are incredibly grateful to our patients for taking these changes in stride during this unprecedented time of much fear and anxiety. Ultimately, this adaptability and flexibility has allowed us to continue to strive toward our most important goal, which is always our patients’ well-being and safety. “ By working with NJIT, we were able to get access to faculty with deep knowledge in areas critical to our mission, and to the newest equipment and techniques without having to make large initial capital investments. Most importantly, we gained early access to future talent. ” - Robert Cohen CTO & VP of R&D at Stryker